MLA 0.00% 8.5¢ medical australia limited

the acquisition means nothing..., page-4

  1. 798 Posts.
    lightbulb Created with Sketch. 10
    absolutely agree on the financial results. However, given the relatively lengthy wait for official reports, the market will still take this onboard and react accordingly.

    In my mind any news that increases the profile and interest in MLA is helpful to existing shareholders.

    I don't see MLA appreciating back to 4c overnight, however I think it was oversold over the past year (hence why I've entered & topped up) and see no reason why it can't reclaim some lost ground back into the 1.1c-1.6c range.

    DYOR.
 
watchlist Created with Sketch. Add MLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.